Attached files

file filename
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION - GlobeStar Therapeutics Corpex_31-1.txt
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION - GlobeStar Therapeutics Corpex_31-2.txt
10-Q - FORM 10-Q FOR 03-31-2011 - GlobeStar Therapeutics Corpform_10-q.txt


                                  EXHIBIT 32.1

                           SECTION 1350 CERTIFICATION

         In connection with the quarterly report of First Titan Corp. (the
"Company") on Form 10-Q for the period ended March 31, 2011 as filed with the
Securities and Exchange Commission (the "Report"), I, Robert Tatar, President of
the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

         1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

May 4, 2011                            /s/ Robert Tatar
                                       ----------------
                                       Robert Tatar, President, Principal
                                       Executive Officer, Principal Financial
                                       and Accounting officer

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon request